NanoSphere Health Sciences Implements Identillect’s Delivery Trust® to Safeguard Cutting-Edge Research & Technology

IRVINE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Identillect Technologies Corp. (the "Company" or "Identillect") (TSX-V:ID) (OTCQB:IDTLF) (FRANKFURT:8ID), a trusted leading provider of intellectual property safeguarding email security, announced today NanoSphere Health Sciences Inc. (“NanoSphere”) has implemented Delivery Trust^® organization-wide to secure sensitive email communications and proprietary research data.

NanoSphere, which recently became publicly traded on the Canadian Securities Exchange (CSE:NSHS), is commercializing its proprietary NanoSphere Delivery System™. This cutting-edge delivery platform is up to six times more bioavailable than existing technologies, meaning delivery of vital nutraceuticals, supplements, pharmaceuticals, and cannabis extracts are vastly more effective. With over twenty years of invested research and development on this revolutionary system, NanoSphere President David Sutton states, “As we continue to develop our growing portfolio of products leveraging our NanoSphere Delivery System, ease of communication while remaining secure is paramount to the successful continued delivery of industry-changing technologies. Identillect’s Delivery Trust email security enables us to facilitate this level of security, confidence and communication channels.”   

According to KPMG Institute’s 2017 Report: Life Sciences Innovation and Cyber Security: Inseparable, intellectual property is identified as one of the most vulnerable assets in life science firms, second only to financial information. Todd Sexton, CEO of Identillect Technologies states, “There are inherent security concerns present whenever a company has developed game-changing technologies. NanoSphere has taken an appropriately proactive stance to protecting their sensitive information by entrusting Delivery Trust to not only safeguard this information, but streamline the process of development and communication between departments. Identillect is pleased to be able to provide technological assistance to growing public companies who are also innovating exciting new technologies like Identillect continues to do in the security space.”

About NanoSphere Health Sciences
NanoSphere, through its wholly owned operating subsidiary, is a biotechnology firm specializing in the creation of the NanoSphere Delivery System™, a revolutionary platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries, and beyond.  The patent-pending NanoSphere Delivery System™ represents one of the most important developments for advancing the non-invasive and user-friendly delivery of biological agents in over 25 years. 

About Identillect
Identillect Technologies is the leading provider of email encryption service Delivery Trust^®, empowering enterprises of all sizes to protect their business and their client’s critical information against cyber security attacks. 

Delivery Trust^® is an award-winning, multi-platform plug-in, which gives users complete control of their emails, for one low price. One simple integration complies with all regulations and most importantly provides peace of mind. 

For more information, or your free trial, please visit www.identillect.com

On Behalf of the Board of Directors of:

IDENTILLECT TECHNOLOGIES CORP.

Todd Sexton
Chief Executive Officer
Tel: [phone]
Email: [e-mail]

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking.  Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements.  Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions.  There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties.  We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.